Interactions between RAMP2 and CRF receptors: The effect of receptor subtypes, splice variants and cell context.
Biochimica et biophysica acta. Biomembranes
MetadataShow full item record
Bailey, S., Harris, M., Barkan, K., Winfield, I., Harper, M., Simms, J., Ladds, G., et al. (2019). Interactions between RAMP2 and CRF receptors: The effect of receptor subtypes, splice variants and cell context.. Biochimica et biophysica acta. Biomembranes, 1861 (5), 997-1003. https://doi.org/10.1016/j.bbamem.2019.02.008
Corticotrophin releasing factor (CRF) acts via two family B G-protein-coupled receptors, CRFR1 and CRFR2. Additional subtypes exist due to alternative splicing. CRFR1α is the most widely expressed subtype and lacks a 29-residue insert in the first intracellular loop that is present in CRFR1β. It has been shown previously that co-expression of CRFR1β with receptor activity modifying protein 2 (RAMP2) in HEK 293S cells increased the cell-surface expression of both proteins suggesting a physical interaction as seen with RAMPs and calcitonin receptor-like receptor (CLR). This study investigated the ability of CRFR1α, CRFR1β and CRFR2β to promote cell-surface expression of FLAG-tagged RAMP2. Four different cell-lines were utilised to investigate the effect of varying cellular context; COS-7, HEK 293T, HEK 293S and [ΔCTR]HEK 293 (which lacks endogenous calcitonin receptor). In all cell-lines, CRFR1α and CRFR1β enhanced RAMP2 cell-surface expression. The magnitude of the effect on RAMP2 was dependent on the cell-line ([ΔCTR]HEK 293 > COS-7 > HEK 293T > HEK 293S). RT-PCR indicated this variation may relate to differences in endogenous RAMP expression between cell types. Furthermore, pre-treatment with CRF resulted in a loss of cell-surface FLAG-RAMP2 when it was co-expressed with CRFR1 subtypes. CRFR2β co-expression had no effect on RAMP2 in any cell-line. Molecular modelling suggests that the potential contact interface between the extracellular domains of RAMP2 and CRF receptor subtypes is smaller than that of RAMP2 and CRL, the canonical receptor:RAMP pairing, assuming a physical interaction. Furthermore, a specific residue difference between CRFR1 subtypes (glutamate) and CRFR2β (histidine) in this interface region may impair CRFR2β:RAMP2 interaction by electrostatic repulsion.
COS Cells, Animals, Humans, Receptors, Corticotropin-Releasing Hormone, Alternative Splicing, Models, Molecular, HEK293 Cells, Receptor Activity-Modifying Protein 2, Chlorocebus aethiops
Leverhulme Trust (via University of Essex) (DBG3000)
External DOI: https://doi.org/10.1016/j.bbamem.2019.02.008
This record's URL: https://www.repository.cam.ac.uk/handle/1810/290194